Mobile Marketing in the Pharmaceutical Industry: Benefits, Costs and Risks

The project will to look into the increasing trend for the mobile marketing worldwide and in particular the pharmaceutical industry. Afterwards will identify the list of the major benefits that can drive revenue for the pharmaceutical companies. Then, a costing analysis will be initiated to evaluate...

Full description

Bibliographic Details
Main Author: Nofal, Hani
Format: Dissertation (University of Nottingham only)
Language:English
Published: 2011
Online Access:https://eprints.nottingham.ac.uk/24888/
_version_ 1848792877362053120
author Nofal, Hani
author_facet Nofal, Hani
author_sort Nofal, Hani
building Nottingham Research Data Repository
collection Online Access
description The project will to look into the increasing trend for the mobile marketing worldwide and in particular the pharmaceutical industry. Afterwards will identify the list of the major benefits that can drive revenue for the pharmaceutical companies. Then, a costing analysis will be initiated to evaluate the budget of implementing such initiatives by exploring the type of cost of implementing such tools and giving specific case analysis for implementing Smartphone apps for Pfizer within for the coming two years. Finally there will be dissuasion on the list of risks and challenges that might face such initiatives.
first_indexed 2025-11-14T18:51:23Z
format Dissertation (University of Nottingham only)
id nottingham-24888
institution University of Nottingham Malaysia Campus
institution_category Local University
language English
last_indexed 2025-11-14T18:51:23Z
publishDate 2011
recordtype eprints
repository_type Digital Repository
spelling nottingham-248882017-12-28T23:36:54Z https://eprints.nottingham.ac.uk/24888/ Mobile Marketing in the Pharmaceutical Industry: Benefits, Costs and Risks Nofal, Hani The project will to look into the increasing trend for the mobile marketing worldwide and in particular the pharmaceutical industry. Afterwards will identify the list of the major benefits that can drive revenue for the pharmaceutical companies. Then, a costing analysis will be initiated to evaluate the budget of implementing such initiatives by exploring the type of cost of implementing such tools and giving specific case analysis for implementing Smartphone apps for Pfizer within for the coming two years. Finally there will be dissuasion on the list of risks and challenges that might face such initiatives. 2011-09-08 Dissertation (University of Nottingham only) NonPeerReviewed application/pdf en https://eprints.nottingham.ac.uk/24888/2/Indv-managementproject-Sept2011.pdf Nofal, Hani (2011) Mobile Marketing in the Pharmaceutical Industry: Benefits, Costs and Risks. [Dissertation (University of Nottingham only)] (Unpublished)
spellingShingle Nofal, Hani
Mobile Marketing in the Pharmaceutical Industry: Benefits, Costs and Risks
title Mobile Marketing in the Pharmaceutical Industry: Benefits, Costs and Risks
title_full Mobile Marketing in the Pharmaceutical Industry: Benefits, Costs and Risks
title_fullStr Mobile Marketing in the Pharmaceutical Industry: Benefits, Costs and Risks
title_full_unstemmed Mobile Marketing in the Pharmaceutical Industry: Benefits, Costs and Risks
title_short Mobile Marketing in the Pharmaceutical Industry: Benefits, Costs and Risks
title_sort mobile marketing in the pharmaceutical industry: benefits, costs and risks
url https://eprints.nottingham.ac.uk/24888/